|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/505 | |
| C07D 403/04 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2925744 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13859400.7 |
| Europos patento paraiškos padavimo data | 2013-11-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2013/051387 |
| Data | 2013-11-26 |
| (87) | Numeris | WO 2014/084778 |
| Data | 2014-06-05 |
| (30) | Numeris | Data | Šalis |
| 1251332 | 2012-11-27 | SE | |
| 201261797022 P | 2012-11-27 | US |
| (72) |
SCOBIE, Martin, SE
HELLEDAY, Thomas, SE
KOOLMEISTER, Tobias, SE
JACQUES, Sylvain, FR
DESROSES, Matthieu, SE
JACQUES-CORDONNIER, Marie-Caroline, FR
|
| (73) |
Thomas Helledays Stiftelse För Medicinsk Forskning,
c/o Oxcia AB Norrbackagatan 70 C, 113 34 Stockholm,
SE
|
| (54) | PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER |